Hong Fang Song

Hong Fang Song appears in our data through filings on CG Oncology, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 29 January 2024 to 3 September 2025, the count stands at 11 filings.

The open-market side counts 1 purchase for €4.6M alongside 7 sales for €41.8M. The net balance comes to €37.2M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2025 alone, the filings show no purchases and 4 sales.

The record was last updated on 4 September 2025 with an open-market sale (€2,484) in CG Oncology, Inc. The last purchase on record was published on 31 January 2024, which is 998 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.